title: [The first results of phase IIA of clinical studies of photodynamic therapy for subretinal neovascular membranes with photosense].
abstract: The subretinal neovascular membrane (SNM) is a common complication of diseases, such as senile macular degeneration, myopia, pseudohistoplasmic syndrome, and many others. There is no algorithm of treatment for this pathology in today's ophthalmological care; however, many authors have arrived at the conclusion that photodynamic therapy (PDT) plays a major role in solving this difficult problem. Fifteen (18 eyes) patients, including 8 (8 eyes) patients diagnosed as having senile macular degeneration and SNM and 7 (10 eyes) patients diagnosed as having complicated high-grade myopia, and 3 were diagnosed as having bilateral SNM. The Russian agent Photosense, 0.05 mg/kg, was used as a photosensitizer. PDT was performed on day 3 after administration of the agent according to the peak of accumulation and the maximum laser concentration gradient at a wavelength of 675 nm and a light dose of 120 J/cm2. Good functional and angiographic results may be observed after the first 3 months of a prospective controlled open-labeled study of the efficiency of PDT with Photosense; however, longer follow-ups and larger groups of patients are required to make a final assessment of this treatment.
authors.forename: S E
authors.initials: SE
authors.lastname: Avetisov
authors.forename: M V
authors.initials: MV
authors.lastname: Budzinskaia
authors.forename: V G
authors.initials: VG
authors.lastname: Likhvantseva
authors.forename: I V
authors.initials: IV
authors.lastname: Gurova
authors.forename: V B
authors.initials: VB
authors.lastname: Loshchenov
authors.forename: S A
authors.initials: SA
authors.lastname: Shevchik
authors.forename: S G
authors.initials: SG
authors.lastname: Kuz'min
authors.forename: G N
authors.initials: GN
authors.lastname: Vorozhtsov
mesh_terms: D000328:Adult; D000368:Aged; D005500:Follow-Up Studies; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008268:Macular Degeneration / Q000150:complications; D008875:Middle Aged; D009216:Myopia / Q000150:complications; D009942:Organometallic Compounds / Q000627:therapeutic use*; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D011446:Prospective Studies; D015861:Retinal Neovascularization / Q000188:drug therapy*; D013997:Time Factors
chemical_list: D007211:Indoles; D009942:Organometallic Compounds; D017319:Photosensitizing Agents; C048577:aluminum tetrasulfophthalocyanine